Literature DB >> 33723453

Tracking the emergence of new SARS-CoV-2 variants in South Africa.

Anise N Happi1, Chinedu A Ugwu1,2, Christian T Happi3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33723453     DOI： 10.1038/s41591-021-01265-1

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

Review 1.  Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.

Authors:  Stanislav A Groppa; Dumitru Ciolac; Carolina Duarte; Christopher Garcia; Daniela Gasnaș; Pavel Leahu; Daniela Efremova; Alexandru Gasnaș; Tatiana Bălănuță; Daniela Mîrzac; Alexandru Movila
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Genomic surveillance of SARS-CoV-2 in Puerto Rico reveals emergence of an autochthonous lineage and early detection of variants.

Authors:  Gilberto A Santiago; Betzabel Flores; Glenda L Gonzalez; Keyla N Charriez; Limari Cora-Huertas; Hannah R Volkman; Steven Van Belleghem; Vanessa Rivera-Amill; Laura E Adams; Melissa Marzan; Lorena Hernandez; Iris Cardona; Eduardo O'Neill; Gabriela Paz-Bailey; Riccardo Papa; Jorge L Munoz-Jordan
Journal:  Res Sq       Date:  2022-01-20

3.  First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.

Authors:  Leira Fernández-Bastit; Jordi Rodon; Edwards Pradenas; Silvia Marfil; Benjamin Trinité; Mariona Parera; Núria Roca; Anna Pou; Guillermo Cantero; Cristina Lorca-Oró; Jorge Carrillo; Nuria Izquierdo-Useros; Bonaventura Clotet; Marc Noguera-Julián; Julià Blanco; Júlia Vergara-Alert; Joaquim Segalés
Journal:  Viruses       Date:  2021-12-16       Impact factor: 5.048

4.  Computational construction of a glycoprotein multi-epitope subunit vaccine candidate for old and new South-African SARS-CoV-2 virus strains.

Authors:  Olugbenga Oluseun Oluwagbemi; Elijah Kolawole Oladipo; Emmanuel Oluwatobi Dairo; Ayodele Eugene Ayeni; Boluwatife Ayobami Irewolede; Esther Moradeyo Jimah; Moyosoluwa Precious Oyewole; Boluwatife Mary Olawale; Hadijat Motunrayo Adegoke; Adewale Joseph Ogunleye
Journal:  Inform Med Unlocked       Date:  2022-01-15

5.  The Dominance of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 and Its Sublineages and Associations with Mortality during the COVID-19 Pandemic in India between 2020 and 2021.

Authors:  Bakilapadavu Venkatraja; Gali Srilakshminarayana; Ballamoole Krishna Kumar
Journal:  Am J Trop Med Hyg       Date:  2021-11-17       Impact factor: 3.707

6.  A SARS-CoV-2 Neutralization Assay Using Single Molecule Arrays.

Authors:  Tal Gilboa; Limor Cohen; Chi-An Cheng; Roey Lazarovits; Augusta Uwamanzu-Nna; Isaac Han; Kettner Griswold; Nick Barry; David B Thompson; Richie E Kohman; Ann E Woolley; Elizabeth W Karlson; David R Walt
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-05       Impact factor: 15.336

7.  First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain.

Authors:  Sandra Barroso-Arévalo; Lidia Sánchez-Morales; Marta Pérez-Sancho; Lucas Domínguez; José M Sánchez-Vizcaíno
Journal:  Front Vet Sci       Date:  2022-04-01

8.  Genomic surveillance of SARS-CoV-2 in Puerto Rico enabled early detection and tracking of variants.

Authors:  Gilberto A Santiago; Betzabel Flores; Glenda L González; Keyla N Charriez; Limari Cora Huertas; Hannah R Volkman; Steven M Van Belleghem; Vanessa Rivera-Amill; Laura E Adams; Melissa Marzán; Lorena Hernández; Iris Cardona; Eduardo O'Neill; Gabriela Paz-Bailey; Riccardo Papa; Jorge L Muñoz-Jordan
Journal:  Commun Med (Lond)       Date:  2022-08-11

Review 9.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

10.  SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.

Authors:  Tatjana Vilibic-Cavlek; Vladimir Stevanovic; Maja Ilic; Ljubo Barbic; Krunoslav Capak; Irena Tabain; Jasna Lenicek Krleza; Thomas Ferenc; Zeljka Hruskar; Renata Zrinski Topic; Vanja Kaliterna; Arlen Antolovic-Pozgain; Jasmina Kucinar; Iva Koscak; Dijana Mayer; Mario Sviben; Ljiljana Antolasic; Ljiljana Milasincic; Lovro Bucic; Ivana Ferencak; Bernard Kaic
Journal:  Pathogens       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.